On Tuesday, Bausch Health Companies Inc (NYSE: BHC) was 5.16% up from the session before settling in for the closing price of $7.17. A 52-week range for BHC has been $3.96 – $11.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 2.48%. When this article was written, the company’s average yearly earnings per share was at 12.76%. With a float of $290.94 million, this company’s outstanding shares have now reached $367.84 million.
The extent of productivity of a business whose workforce counts for 20700 workers is very important to gauge. In terms of profitability, gross margin is 62.52%, operating margin of 16.58%, and the pretax margin is 1.74%.
Bausch Health Companies Inc (BHC) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Bausch Health Companies Inc stocks. The insider ownership of Bausch Health Companies Inc is 20.90%, while institutional ownership is 59.64%. The most recent insider transaction that took place on Dec 02 ’24, was worth 3,674. In this transaction EVP, General Counsel of this company sold 440 shares at a rate of $8.35, taking the stock ownership to the 433,066 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Officer proposed sale 440 for $8.35, making the entire transaction worth $3,674.
Bausch Health Companies Inc (BHC) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 12.76% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.97% during the next five years compared to 52.33% growth over the previous five years of trading.
Bausch Health Companies Inc (NYSE: BHC) Trading Performance Indicators
You can see what Bausch Health Companies Inc (BHC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.29. Likewise, its price to free cash flow for the trailing twelve months is 2.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit 0.87 in the next quarter and is forecasted to reach 4.72 in one year’s time.
Technical Analysis of Bausch Health Companies Inc (BHC)
The latest stats from [Bausch Health Companies Inc, BHC] show that its last 5-days average volume of 3.47 million was superior to 3.37 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 84.46%. Additionally, its Average True Range was 0.34.
During the past 100 days, Bausch Health Companies Inc’s (BHC) raw stochastic average was set at 38.07%, which indicates a significant decrease from 89.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.02% in the past 14 days, which was higher than the 48.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.37, while its 200-day Moving Average is $7.24. Now, the first resistance to watch is $7.76. This is followed by the second major resistance level at $7.98. The third major resistance level sits at $8.26. If the price goes on to break the first support level at $7.26, it is likely to go to the next support level at $6.98. The third support level lies at $6.76 if the price breaches the second support level.
Bausch Health Companies Inc (NYSE: BHC) Key Stats
There are 367,934K outstanding shares of the company, which has a market capitalization of 2.77 billion. As of now, sales total 9,625 M while income totals -46,000 K. Its latest quarter income was 2,559 M while its last quarter net income were 93,000 K.
